Cargando…
Therapeutic Efficacy and Radiobiological Effects of Boric-Acid-Mediated BNCT in an Osteosarcoma-Bearing SD Rat Model
Background: Osteosarcoma (OS) is the most common primary malignancy of the bone and is notoriously resistant to radiation therapy. High-dose cytotoxic chemotherapy and surgical resection have improved the survival rate and prognosis of patients with OS. Nonetheless, treatment challenges remain when...
Autores principales: | Hsu, Chen-Fang, Liu, Hong-Ming, Peir, Jinn-Jer, Liao, Jiunn-Wang, Chen, Kuan-Sheng, Chen, Yi-Wei, Chuang, Yung-Jen, Chou, Fong-In |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964381/ https://www.ncbi.nlm.nih.gov/pubmed/36836871 http://dx.doi.org/10.3390/life13020514 |
Ejemplares similares
-
NeuTHOR Station—A Novel Integrated Platform for Monitoring BNCT Clinical Treatment, Animal and Cell Irradiation Study at THOR
por: Huang, Yu-Shiang, et al.
Publicado: (2023) -
Advances in Boron Neutron Capture Therapy (BNCT) for Recurrent Intracranial Meningioma
por: Lan, Tien-Li, et al.
Publicado: (2023) -
A Novel Approach to Design and Evaluate BNCT Neutron Beams Combining Physical, Radiobiological, and Dosimetric Figures of Merit
por: Postuma, Ian, et al.
Publicado: (2021) -
Chitosan-Boric Acid Scaffolds for Doxorubicin Delivery in the Osteosarcoma Treatment
por: Dornjak, Luka, et al.
Publicado: (2022) -
Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using (10)B-p-Boronophenylalanine (BPA) with Special Reference to the Radiobiological Basis and Clinical Results
por: Fukuda, Hiroshi
Publicado: (2021)